By: CHRISTOPHER SNOWBECK
The state is investigating how Pennsylvania officials used drug company payments while they were developing schizophrenia treatment guidelines that featured those companies’ medications.
The drug company money had been deposited in an unauthorized account that the state officials used for a variety of purposes, including trips to out-of-state professional meetings.
The treatment guidelines promote the use of newer schizophrenia medicines for about 900 patients in state psychiatric hospitals. Since the guidelines were put in place between 2001 and 2003, many patients have seen improvements, according to patient advocates…